Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Immunotherapeutic Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Johnson and Johnson
AbbVie
AstraZeneca
Amgen
Roche
Merck
Bristol-Mysers Squibb
ELI Lilly
Novartis
By Type:
Interferon
Monoclonal Antibody
Checkpoint Inhibitor
Vaccines
By Application:
Hospitals
Clinics
Other
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Immunotherapeutic Drugs Market Overview 2018-2029
-
1.1 China Immunotherapeutic Drugs Industry Development Overview
-
1.2 China Immunotherapeutic Drugs Industry Development History
-
1.3 China Immunotherapeutic Drugs Industry Market Size (2018-2029)
-
1.4 China Immunotherapeutic Drugs Market Analysis by Type from Production Side
-
1.4.1 China Immunotherapeutic Drugs Production Volume, Production Value and Growth Rate of Interferon (2018-2029)
-
1.4.2 China Immunotherapeutic Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibody (2018-2029)
-
1.4.3 China Immunotherapeutic Drugs Production Volume, Production Value and Growth Rate of Checkpoint Inhibitor (2018-2029)
-
1.4.4 China Immunotherapeutic Drugs Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
1.5 China Immunotherapeutic Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Immunotherapeutic Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Immunotherapeutic Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.5.3 China Immunotherapeutic Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.6 China Immunotherapeutic Drugs Market Analysis by Region
-
1.6.1 North China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Immunotherapeutic Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Immunotherapeutic Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Immunotherapeutic Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Immunotherapeutic Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Immunotherapeutic Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Immunotherapeutic Drugs Industry Development
Chapter 3 Immunotherapeutic DrugsIndustry Chain Analysis
-
3.1 Immunotherapeutic Drugs Industry Chain
-
3.2 Immunotherapeutic Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Immunotherapeutic Drugs Market
-
3.3 Immunotherapeutic Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Immunotherapeutic Drugs Market
Chapter 4 China Immunotherapeutic Drugs Market, by Type
-
4.1 China Immunotherapeutic Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Immunotherapeutic Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Immunotherapeutic Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Immunotherapeutic Drugs Production Volume and Growth Rate of Interferon
-
4.5.2 China Immunotherapeutic Drugs Production Volume and Growth Rate of Monoclonal Antibody
-
4.5.3 China Immunotherapeutic Drugs Production Volume and Growth Rate of Checkpoint Inhibitor
-
4.5.4 China Immunotherapeutic Drugs Production Volume and Growth Rate of Vaccines
Chapter 5 China Immunotherapeutic Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Immunotherapeutic Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Immunotherapeutic Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Immunotherapeutic Drugs Market Size and Growth Rate of Hospitals
-
5.5.2 China Immunotherapeutic Drugs Market Size and Growth Rate of Clinics
-
5.5.3 China Immunotherapeutic Drugs Market Size and Growth Rate of Other
Chapter 6 China Immunotherapeutic Drugs Market, by Region
-
6.1 China Immunotherapeutic Drugs Production Volume and Production Value, by Region
-
6.2 China Immunotherapeutic Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Immunotherapeutic Drugs Market Analysis
-
7.1 North China Immunotherapeutic Drugs Market, by Type
-
7.2 North China Immunotherapeutic Drugs Market, by Application
Chapter 8 Central China Immunotherapeutic Drugs Market Analysis
-
8.1 Central China Immunotherapeutic Drugs Market, by Type
-
8.2 Central China Immunotherapeutic Drugs Market, by Application
Chapter 9 South China Immunotherapeutic Drugs Market Analysis
-
9.1 South China Immunotherapeutic Drugs Market, by Type
-
9.2 South China Immunotherapeutic Drugs Market, by Application
Chapter 10 East China Immunotherapeutic Drugs Market Analysis
-
10.1 East China Immunotherapeutic Drugs Market, by Type
-
10.2 East China Immunotherapeutic Drugs Market, by Application
Chapter 11 Northeast China Immunotherapeutic Drugs Market Analysis
-
11.1 Northeast China Immunotherapeutic Drugs Market, by Type
-
11.2 Northeast China Immunotherapeutic Drugs Market, by Application
Chapter 12 Southwest China Immunotherapeutic Drugs Market Analysis
-
12.1 Southwest China Immunotherapeutic Drugs Market, by Type
-
12.2 Southwest China Immunotherapeutic Drugs Market, by Application
Chapter 13 Northwest China Immunotherapeutic Drugs Market Analysis
-
13.1 Northwest China Immunotherapeutic Drugs Market, by Type
-
13.2 Northwest China Immunotherapeutic Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Johnson and Johnson
-
14.1.1 Johnson and Johnson Company Profile
-
14.1.2 Johnson and Johnson Immunotherapeutic Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 AbbVie
-
14.2.1 AbbVie Company Profile
-
14.2.2 AbbVie Immunotherapeutic Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Profile
-
14.3.2 AstraZeneca Immunotherapeutic Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amgen
-
14.4.1 Amgen Company Profile
-
14.4.2 Amgen Immunotherapeutic Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Roche
-
14.5.1 Roche Company Profile
-
14.5.2 Roche Immunotherapeutic Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Merck
-
14.6.1 Merck Company Profile
-
14.6.2 Merck Immunotherapeutic Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Bristol-Mysers Squibb
-
14.7.1 Bristol-Mysers Squibb Company Profile
-
14.7.2 Bristol-Mysers Squibb Immunotherapeutic Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 ELI Lilly
-
14.8.1 ELI Lilly Company Profile
-
14.8.2 ELI Lilly Immunotherapeutic Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Novartis
-
14.9.1 Novartis Company Profile
-
14.9.2 Novartis Immunotherapeutic Drugs Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Immunotherapeutic Drugs Industry Research Conclusions
-
15.2 Immunotherapeutic Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Immunotherapeutic Drugs Industry Market Size (2018-2029)
-
Figure China Immunotherapeutic Drugs Production Volume, Production Value and Growth Rate of Interferon (2018-2029)
-
Figure China Immunotherapeutic Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibody (2018-2029)
-
Figure China Immunotherapeutic Drugs Production Volume, Production Value and Growth Rate of Checkpoint Inhibitor (2018-2029)
-
Figure China Immunotherapeutic Drugs Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
Figure China Immunotherapeutic Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Immunotherapeutic Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure China Immunotherapeutic Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure North China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Immunotherapeutic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Immunotherapeutic Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Immunotherapeutic Drugs Market Share by Type in 2018
-
Figure China Immunotherapeutic Drugs Market Share by Type in 2023
-
Figure China Immunotherapeutic Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Immunotherapeutic Drugs Production Volume and Growth Rate of Interferon (2018-2023)
-
Figure China Immunotherapeutic Drugs Production Volume and Growth Rate of Monoclonal Antibody (2018-2023)
-
Figure China Immunotherapeutic Drugs Production Volume and Growth Rate of Checkpoint Inhibitor (2018-2023)
-
Figure China Immunotherapeutic Drugs Production Volume and Growth Rate of Vaccines (2018-2023)
-
Figure China Immunotherapeutic Drugs Market Share by Application in 2018
-
Figure China Immunotherapeutic Drugs Market Share by Application in 2023
-
Figure China Immunotherapeutic Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Immunotherapeutic Drugs Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Immunotherapeutic Drugs Market Size and Growth Rate of Clinics (2018-2023)
-
Figure China Immunotherapeutic Drugs Market Size and Growth Rate of Other (2018-2023)
-
Table China Immunotherapeutic Drugs Production Volume by Region (2018-2023)
-
Table China Immunotherapeutic Drugs Production Volume Share by Region (2018-2023)
-
Figure China Immunotherapeutic Drugs Production Volume Share by Region (2018-2023)
-
Table China Immunotherapeutic Drugs Production Value by Region (2018-2023)
-
Table China Immunotherapeutic Drugs Production Value Share by Region (2018-2023)
-
Figure China Immunotherapeutic Drugs Production Value Share by Region (2018-2023)
-
Table China Immunotherapeutic Drugs Sales Volume by Region (2018-2023)
-
Table China Immunotherapeutic Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Immunotherapeutic Drugs Sales Volume Share by Region (2018-2023)
-
Table China Immunotherapeutic Drugs Sales Value by Region (2018-2023)
-
Table China Immunotherapeutic Drugs Sales Value Share by Region (2018-2023)
-
Figure China Immunotherapeutic Drugs Sales Value Share by Region (2018-2023)
-
Table North China Immunotherapeutic Drugs Production Volume by Type (2018-2023)
-
Table North China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Table North China Immunotherapeutic Drugs Sales Volume by Application (2018-2023)
-
Table North China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Immunotherapeutic Drugs Production Volume by Type (2018-2023)
-
Table Central China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Immunotherapeutic Drugs Sales Volume by Application (2018-2023)
-
Table Central China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Immunotherapeutic Drugs Production Volume by Type (2018-2023)
-
Table South China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Table South China Immunotherapeutic Drugs Sales Volume by Application (2018-2023)
-
Table South China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Immunotherapeutic Drugs Production Volume by Type (2018-2023)
-
Table East China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Table East China Immunotherapeutic Drugs Sales Volume by Application (2018-2023)
-
Table East China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Immunotherapeutic Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Immunotherapeutic Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Immunotherapeutic Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Immunotherapeutic Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Immunotherapeutic Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Immunotherapeutic Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Immunotherapeutic Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Immunotherapeutic Drugs Sales Volume Share by Application (2018-2023)
-
Table Johnson and Johnson Company Profile
-
Table Johnson and Johnson Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
Table Bristol-Mysers Squibb Company Profile
-
Table Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
Table ELI Lilly Company Profile
-
Table ELI Lilly Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Immunotherapeutic Drugs Revenue, Price and Gross (2018-2023)
-
